during the rapidly evolving subject of oncology investigate, precise and productive mutation screening is essential for creating specific therapies. The KRAS solutions System performs a pivotal function in this landscape by providing comprehensive options for KRAS mutation profiling and Investigation. KRAS mutations, found in approximately 95% of R